Stock listing

TSXV:QPT Quest PharmaTech Inc. Stock

Home listing (TSXV) of Quest PharmaTech Inc.

Follow Quest PharmaTech Inc. into a list and get an email when it puts out news.

Share price · TSXV:QPT

$0.02 CAD 0.00 (0.0%)

Close on Oct 29, 2026

Past year -50.0% · daily closes, Oct 29, 2025 – Oct 29, 2026, adjusted for splits

Day range: $0.02 – $0.02 CADOct 29, 2026
Volume: 2,000 sharesOct 29, 2026
Market cap: $3.38M CADAt the close on Oct 29, 2026 · price × 169.1M shares outstanding
52-week range: $0.02 – $0.05 CADLowest and highest trades, Oct 30, 2025 – Oct 29, 2026
Traded on an average day: $148 CADMedian day 0 shares · 46 days with no trades · last 3 months, Jul 29, 2026 – Oct 29, 2026

Prices by listing

Listing	Last	Change	Volume	Open	High	Low	Previous close	Price from
TSXV:QPT · Home	$0.02 CAD	0.00 (0.0%)	2,000	$0.02	$0.02	$0.02	$0.02	Close on Oct 29, 2026

Daily closes

Last 3 months, Jul 29, 2026 – Oct 29, 2026 · TSXV:QPT · CAD, adjusted for splits

Day	Close	Change	%	Open	High	Low	Volume
Thu, Oct 29	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	2,000
Thu, Oct 22	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Wed, Oct 21	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Tue, Oct 20	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	120,000
Mon, Oct 19	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Oct 16	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	1,500
Thu, Oct 15	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Wed, Oct 14	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Tue, Oct 13	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Oct 9	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Thu, Oct 8	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Wed, Oct 7	$0.02	-0.01	-33.3%	$0.02	$0.02	$0.02	4,000
Tue, Oct 6	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Mon, Oct 5	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Fri, Oct 2	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Thu, Oct 1	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Wed, Sep 30	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Tue, Sep 29	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Mon, Sep 28	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Fri, Sep 25	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Thu, Sep 24	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	16,000
Wed, Sep 23	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Tue, Sep 22	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Mon, Sep 21	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Fri, Sep 18	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Thu, Sep 17	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	0
Wed, Sep 16	$0.03	+0.01	+50.0%	$0.03	$0.03	$0.03	105,200
Tue, Sep 15	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Mon, Sep 14	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Sep 11	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Thu, Sep 10	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Wed, Sep 9	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Tue, Sep 8	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Sep 4	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Thu, Sep 3	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Wed, Sep 2	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Tue, Sep 1	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Mon, Aug 31	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Aug 28	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Thu, Aug 27	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	10,000
Wed, Aug 26	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Tue, Aug 25	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Mon, Aug 24	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Aug 21	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Thu, Aug 20	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Wed, Aug 19	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	10,000
Tue, Aug 18	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Mon, Aug 17	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Aug 14	$0.02	-0.01	-33.3%	$0.02	$0.02	$0.02	5,500
Thu, Aug 13	$0.03	0.00	0.0%	$0.03	$0.03	$0.03	3,500
Wed, Aug 12	$0.03	+0.01	+50.0%	$0.03	$0.03	$0.03	40,000
Tue, Aug 11	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Mon, Aug 10	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Aug 7	$0.02	-0.01	-33.3%	$0.02	$0.02	$0.02	10,800
Thu, Aug 6	$0.03	+0.01	+50.0%	$0.03	$0.03	$0.03	21,000
Wed, Aug 5	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Tue, Aug 4	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Fri, Jul 31	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Thu, Jul 30	$0.02	0.00	0.0%	$0.02	$0.02	$0.02	0
Wed, Jul 29	$0.02	-0.01	-33.3%	$0.02	$0.02	$0.02	2,000

Ticker: TSXV:QPT
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: TSXV
Currency: CAD

What changed lately

Latest news release · Sep 25, 2026
Quest PharmaTech Announces Change of Chief Executive Officer

Latest news

Quest PharmaTech Announces Change of Chief Executive Officer

Sep 25, 2026

Closed $0.03 (0.0%) on Sep 28, 2026

Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis

May 29, 2026

Closed $0.04 (+33.3%) on Jun 1, 2026

Quest PharmaTech Announces Results from AGM

Aug 27, 2025

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

Jun 10, 2025

Quest PharmaTech Provides Corporate Update

Jun 2, 2025

Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director

May 30, 2024

Quest Receives Cash Dividend Payment from OncoQuest

Jan 30, 2024

Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

Jan 23, 2024

Quest PharmaTech Provides Product Development Update

Jul 10, 2023

Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.

Jun 6, 2023

All Quest PharmaTech Inc. news

Decks

AmrutBio — Investor Presentation (January 2016)
Investor deck · 22 slides · January 2016

Quest PharmaTech Inc. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 2 in the last 12 months · 142 in all · newest Sep 25, 2026 · oldest 2005
Decks: 1 deck · latest January 2016

Where Quest PharmaTech Inc. is listed

Listing	Exchange	Country	Currency
TSXV:QPT · Home listing · This page	TSXV	Canada	CAD
OTC:QPTFF	OTC	United States	USD
Cboe Canada:QPT	Cboe Canada	Canada	CAD

TSXV:QPT Quest PharmaTech Inc. Stock

Prices by listing

Daily closes

What changed lately

Quest PharmaTech Announces Change of Chief Executive Officer

Latest news

Quest PharmaTech Announces Change of Chief Executive Officer

Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis

Quest PharmaTech Announces Results from AGM

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

Quest PharmaTech Provides Corporate Update

Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director

Quest Receives Cash Dividend Payment from OncoQuest

Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

Quest PharmaTech Provides Product Development Update

Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.

Decks

AmrutBio — Investor Presentation (January 2016)

Quest PharmaTech Inc. on 6ix

Where Quest PharmaTech Inc. is listed